Boston Partners Purchases 15,291 Shares of The Pennant Group, Inc. (NASDAQ:PNTG)

Boston Partners grew its position in shares of The Pennant Group, Inc. (NASDAQ:PNTG) by 15.2% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 115,682 shares of the company’s stock after buying an additional 15,291 shares during the quarter. Boston Partners’ holdings in The Pennant Group were worth $2,273,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Allianz Asset Management GmbH bought a new position in The Pennant Group in the 4th quarter valued at $2,351,000. Keeley Teton Advisors LLC purchased a new stake in The Pennant Group during the fourth quarter worth about $603,000. Wasatch Advisors LP raised its position in The Pennant Group by 3.3% in the fourth quarter. Wasatch Advisors LP now owns 1,465,754 shares of the company’s stock worth $20,403,000 after acquiring an additional 46,484 shares during the period. Sei Investments Co. boosted its stake in The Pennant Group by 679.7% in the first quarter. Sei Investments Co. now owns 136,026 shares of the company’s stock valued at $2,670,000 after acquiring an additional 118,581 shares during the last quarter. Finally, 8 Knots Management LLC purchased a new stake in shares of The Pennant Group during the 4th quarter worth approximately $25,578,000. Hedge funds and other institutional investors own 85.88% of the company’s stock.

The Pennant Group Price Performance

Shares of The Pennant Group stock traded down $0.65 on Friday, reaching $29.26. The stock had a trading volume of 201,016 shares, compared to its average volume of 208,326. The business’s 50 day moving average is $24.94 and its two-hundred day moving average is $21.07. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.51. The Pennant Group, Inc. has a 1 year low of $10.31 and a 1 year high of $31.23. The company has a market cap of $879.15 million, a P/E ratio of 54.19, a price-to-earnings-growth ratio of 3.17 and a beta of 2.00.

The Pennant Group (NASDAQ:PNTG) last announced its quarterly earnings results on Monday, May 6th. The company reported $0.15 EPS for the quarter, meeting the consensus estimate of $0.15. The Pennant Group had a net margin of 2.86% and a return on equity of 13.42%. The firm had revenue of $156.92 million during the quarter, compared to the consensus estimate of $146.01 million. As a group, research analysts anticipate that The Pennant Group, Inc. will post 0.73 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the company. Truist Financial increased their price target on The Pennant Group from $25.00 to $28.00 and gave the stock a “hold” rating in a research note on Monday, July 15th. Royal Bank of Canada increased their target price on shares of The Pennant Group from $21.00 to $26.00 and gave the stock an “outperform” rating in a research report on Thursday, May 9th. Finally, Stephens reissued an “overweight” rating and issued a $25.00 price target on shares of The Pennant Group in a research report on Thursday, June 20th.

About The Pennant Group

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.